ASCO Updates 177Lutetium-PSMA-617 Recommendations - Renal and Urology News
Clinicians now have a third recommended radiotracer option for use in PET PSMA scans to determine treatment eligibility. ASCO has added another radiotracer to its recommended options for use in PSMA PET scans to determine 177lutetium-PSMA-617 treatment eligibility.
Source: renalandurologynews.com